America green lights new stem cell trial for MS Published: 28 July 2021 A Phase 2 clinical trial to assess the efficacy of using mesenchymal stem cells (MSCs) to treat mild to moderate multiple sclerosis (MS) will go ahead in the US after the Food and Drug Administration (FDA) gave